Pax genes: Regulators of lineage specification and progenitor cell maintenance

Development (Cambridge)

Volumn 141, Issue 4, 2014, Pages 737-751

  Blake, Judith A ^a   Ziman, Melanie R ^a  

^a EDITH COWAN UNIVERSITY   (Australia)

Author keywords

Embryogenesis; Lineage determination; Pax genes

Indexed keywords

PAIRED BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX2; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX4; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PAX7; TRANSCRIPTION FACTOR PAX8; TRANSCRIPTION FACTOR PAX9;

ARTICLE; BRAIN CORTEX; CANCER STEM CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; GENE EXPRESSION; GENE REGULATORY NETWORK; HUMAN; MORPHOGENESIS; NEURAL CREST; NEURAL TUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SKELETAL MUSCLE; SPINAL CORD; SPINE; STEM CELL; TISSUE REGENERATION;

EMBRYOGENESIS; LINEAGE DETERMINATION; PAX GENES;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MODELS, BIOLOGICAL; MUSCULOSKELETAL SYSTEM; NERVOUS SYSTEM; NEURAL CREST; NEURAL PLATE; PAIRED BOX TRANSCRIPTION FACTORS; REGENERATION; STEM CELLS;

EID: 84893263835     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.091785     Document Type: Article

References (228)

1. Acampora, D., Mazan, S., Lallemand, Y., Avantaggiato, V., Maury, M., Simeone, A. and Brûlet, P. (1995). Forebrain and midbrain regions are deleted in Otx2-/-mutants due to a defective anterior neuroectoderm specification during gastrulation. Development 121, 3279-3290.
2. Adameyko, I. and Lallemend, F. (2010). Glial versus melanocyte cell fate choice: Schwann cell precursors as a cellular origin of melanocytes. Cell. Mol. Life Sci. 67, 3037-3055.
3. Adameyko, I., Lallemend, F., Aquino, J. B., Pereira, J. A., Topilko, P., Müller, T., Fritz, N., Beljajeva, A., Mochii, M., Liste, I. et al. (2009). Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin. Cell 139, 366-379.
4. Adham, I. M., Gille, M., Gamel, A. J., Reis, A., Dressel, R., Steding, G., Brand-Saberi, B. and Engel, W. (2005). The scoliosis (sco) mouse: a new allele of Pax1. Cytogenet. Genome Res. 111, 16-26.
5. Agoston, Z. and Schulte, D. (2009). Meis2 competes with the Groucho co-repressor Tle4 for binding to Otx2 and specifies tectal fate without induction of a secondary midbrain-hindbrain boundary organizer. Development 136, 3311-3322.
6. Agoston, Z., Li, N., Haslinger, A., Wizenmann, A. and Schulte, D. (2012). Genetic and physical interaction of Meis2, Pax3 and Pax7 during dorsal midbrain development. BMC Dev. Biol. 12, 10.
7. Amiel, J., Audollent, S., Joly, D., Dureau, P., Salomon, R., Tellier, A. L., Augé, J., Bouissou, F., Antignac, C., Gubler, M. C. et al. (2000). PAX2 mutations in renalcoloboma syndrome: mutational hotspot and germline mosaicism. Eur. J. Hum. Genet. 8, 820-826.
8. Asami, M., Pilz, G. A., Ninkovic, J., Godinho, L., Schroeder, T., Huttner, W. B. and Götz, M. (2011). The role of Pax6 in regulating the orientation and mode of cell division of progenitors in the mouse cerebral cortex. Development 138, 5067-5078.
9. Asher, J. H., Jr, Sommer, A., Morell, R. and Friedman, T. B. (1996). Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome. Hum. Mutat. 7, 30-35.
10. Azuma, N., Nishina, S., Yanagisawa, H., Okuyama, T. and Yamada, M. (1996). PAX6 missense mutation in isolated foveal hypoplasia. Nat. Genet. 13, 141-142.
11. Azuma, N., Yamaguchi, Y., Handa, H., Tadokoro, K., Asaka, A., Kawase, E. and Yamada, M. (2003). Mutations of the PAX6 gene detected in patients with a variety of optic-nerve malformations. Am. J. Hum. Genet. 72, 1565-1570.
12. Bajard, L., Relaix, F., Lagha, M., Rocancourt, D., Daubas, P. and Buckingham, M. E. (2006). A novel genetic hierarchy functions during hypaxial myogenesis: Pax3 directly activates Myf5 in muscle progenitor cells in the limb. Genes Dev. 20, 2450-2464.
13. Balaskas, N., Ribeiro, A., Panovska, J., Dessaud, E., Sasai, N., Page, K. M., Briscoe, J. and Ribes, V. (2012). Gene regulatory logic for reading the Sonic Hedgehog signaling gradient in the vertebrate neural tube. Cell 148, 273-284.
14. Baldwin, C. T., Hoth, C. F., Amos, J. A., da-Silva, E. O. and Milunsky, A. (1992). An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome. Nature 355, 637-638.
15. Baldwin, C. T., Hoth, C. F., Macina, R. A. and Milunsky, A. (1995). Mutations in PAX3 that cause Waardenburg syndrome type I: ten new mutations and review of the literature. Am. J. Med. Genet. 58, 115-122.
16. Balling, R., Deutsch, U. and Gruss, P. (1988). undulated, a mutation affecting the development of the mouse skeleton, has a point mutation in the paired box of Pax 1. Cell 55, 531-535.
17. Barber, T. D., Barber, M. C., Cloutier, T. E. and Friedman, T. B. (1999). PAX3 gene structure, alternative splicing and evolution. Gene 237, 311-319.
18. Barr, F. G., Sellinger, B. and Emanuel, B. S. (1991). Localization of the rhabdomyosarcoma t(2;13) breakpoint on a physical map of chromosome 13. Genomics 11, 941-947.
19. Barr, F. G., Galili, N., Holick, J., Biegel, J. A., Rovera, G. and Emanuel, B. S. (1993). Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat. Genet. 3, 113-117.
20. Barr, F. G., Nauta, L. E., Davis, R. J., Schäfer, B. W., Nycum, L. M. and Biegel, J. A. (1996). In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. Hum. Mol. Genet. 5, 15-21.
21. Barr, F. G., Fitzgerald, J. C., Ginsberg, J. P., Vanella, M. L., Davis, R. J. and Bennicelli, J. L. (1999). Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell lines. Cancer Res. 59, 5443-5448.
22. Basch, M. L. and Bronner-Fraser, M. (2006). Neural crest inducing signals. Adv. Exp. Med. Biol. 589, 24-31.
23. Basch, M. L., Bronner-Fraser, M. and García-Castro, M. I. (2006). Specification of the neural crest occurs during gastrulation and requires Pax7. Nature 441, 218-222.
24. Bel-Vialar, S., Medevielle, F. and Pituello, F. (2007). The on/off of Pax6 controls the tempo of neuronal differentiation in the developing spinal cord. Dev. Biol. 305, 659-673.
25. Ben-Yair, R., Kahane, N. and Kalcheim, C. (2011). LGN-dependent orientation of cell divisions in the dermomyotome controls lineage segregation into muscle and dermis. Development 138, 4155-4166.
26. Bennicelli, J. L., Edwards, R. H. and Barr, F. G. (1996). Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma. Proc. Natl. Acad. Sci. USA 93, 5455-5459.
27. Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K. et al. (2006). A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315-326.
28. Blanchard, A. D., Sinanan, A., Parmantier, E., Zwart, R., Broos, L., Meijer, D., Meier, C., Jessen, K. R. and Mirsky, R. (1996). Oct-6 (SCIP/Tst-1) is expressed in Schwann cell precursors, embryonic Schwann cells, and postnatal myelinating Schwann cells: comparison with Oct-1, Krox-20, and Pax-3. J. Neurosci. Res. 46, 630-640.
29. Bower, M., Salomon, R., Allanson, J., Antignac, C., Benedicenti, F., Benetti, E., Binenbaum, G., Jensen, U. B., Cochat, P., DeCramer, S. et al. (2012). Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database. Hum. Mutat. 33, 457-466.
30. Brand-Saberi, B. and Christ, B. (2000). Evolution and development of distinct cell lineages derived from somites. Curr. Top. Dev. Biol. 48, 1-42.
31. Brent, A. E., Schweitzer, R. and Tabin, C. J. (2003). A somitic compartment of tendon progenitors. Cell 113, 235-248.
32. Britsch, S., Goerich, D. E., Riethmacher, D., Peirano, R. I., Rossner, M., Nave, K. A., Birchmeier, C. and Wegner, M. (2001). The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev. 15, 66-78.
33. Bronner, M. E. (2012). A career at the interface of cell and developmental biology: a view from the crest. Mol. Biol. Cell 23, 4151-4153.
34. Brun, T. and Gauthier, B. R. (2008). A focus on the role of Pax4 in mature pancreatic islet beta-cell expansion and survival in health and disease. J. Mol. Endocrinol. 40, 37-45.
35. Buckingham, M. and Relaix, F. (2007). The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu. Rev. Cell Dev. Biol. 23, 645-673.
36. Buckingham, M., Bajard, L., Chang, T., Daubas, P., Hadchouel, J., Meilhac, S., Montarras, D., Rocancourt, D. and Relaix, F. (2003). The formation of skeletal muscle: from somite to limb. J. Anat. 202, 59-68.
37. Burri, M., Tromvoukis, Y., Bopp, D., Frigerio, G. and Noll, M. (1989). Conservation of the paired domain in metazoans and its structure in three isolated human genes. EMBO J. 8, 1183-1190.
38. Bylund, M., Andersson, E., Novitch, B. G. and Muhr, J. (2003). Vertebrate neurogenesis is counteracted by Sox1-3 activity. Nat. Neurosci. 6, 1162-1168.
39. Carezani-Gavin, M., Clarren, S. K. and Steege, T. (1992). Waardenburg syndrome associated with meningomyelocele. Am. J. Med. Genet. 42, 135-136.
40. Chan, W. Y., Cheung, C. S., Yung, K. M. and Copp, A. J. (2004). Cardiac neural crest of the mouse embryo: axial level of origin, migratory pathway and cell autonomy of the splotch (Sp2H) mutant effect. Development 131, 3367-3379.
41. Charytonowicz, E., Cordon-Cardo, C., Matushansky, I. and Ziman, M. (2009). Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell? Cancer Lett. 279, 126-136.
42. Charytonowicz, E., Matushansky, I., Castillo-Martin, M., Hricik, T., Cordon-Cardo, C. and Ziman, M. (2011). Alternate PAX3 and PAX7 C-terminal isoforms in myogenic differentiation and sarcomagenesis. Clin. Transl. Oncol. 13, 194-203.
43. Chi, N. and Epstein, J. A. (2002). Getting your Pax straight: Pax proteins in development and disease. Trends Genet. 18, 41-47.
44. Cho, E. A., Prindle, M. J. and Dressler, G. R. (2003). BRCT domain-containing protein PTIP is essential for progression through mitosis. Mol. Cell. Biol. 23, 1666-1673.
45. Christ, B., Huang, R. and Wilting, J. (2000). The development of the avian vertebral column. Anat. Embryol. (Berl.) 202, 179-194.
46. Congdon, T., Nguyen, L. Q., Nogueira, C. R., Habiby, R. L., Medeiros-Neto, G. and Kopp, P. (2001). A novel mutation (Q40P) in PAX8 associated with congenital hypothyroidism and thyroid hypoplasia: evidence for phenotypic variability in mother and child. J. Clin. Endocrinol. Metab. 86, 3962-3967.
47. Conway, S. J., Henderson, D. J., Kirby, M. L., Anderson, R. H. and Copp, A. J. (1997). Development of a lethal congenital heart defect in the splotch (Pax3) mutant mouse. Cardiovasc. Res. 36, 163-173.
48. Conway, S. J., Bundy, J., Chen, J., Dickman, E., Rogers, R. and Will, B. M. (2000). Decreased neural crest stem cell expansion is responsible for the conotruncal heart defects within the splotch (Sp(2H)/Pax3 mouse mutant. Cardiovasc. Res. 47, 314-328.
49. Cramer, S. F. and Fesyuk, A. (2012). On the development of neurocutaneous units-implications for the histogenesis of congenital, acquired, and dysplastic nevi. Am. J. Dermatopathol. 34, 60-81.
50. Crawfurd, M. D., Harcourt, R. B. and Shaw, P. A. (1979). Non-progressive cerebellar ataxia, aplasia of pupillary zone of iris, and mental subnormality (Gillespie's syndrome) affecting 3 members of a non-consanguineous family in 2 generations. J. Med. Genet. 16, 373-378.
51. Curran, R. E. and Robb, R. M. (1976). Isolated foveal hypoplasia. Arch. Ophthalmol.94, 48-50.
52. Das, P., Stockton, D. W., Bauer, C., Shaffer, L. G., D'Souza, R. N., Wright, T. and Patel, P. I. (2002). Haploinsufficiency of PAX9 is associated with autosomal dominant hypodontia. Hum. Genet. 110, 371-376.
53. Devriendt, K., Matthijs, G., Van Damme, B., Van Caesbroeck, D., Eccles, M., Vanrenterghem, Y., Fryns, J. P. and Leys, A. (1998). Missense mutation and hexanucleotide duplication in the PAX2 gene in two unrelated families with renalcoloboma syndrome (MIM 120330). Hum. Genet. 103, 149-153.
54. Diao, Y., Guo, X., Li, Y., Sun, K., Lu, L., Jiang, L., Fu, X., Zhu, H., Sun, H., Wang, H. et al. (2012). Pax3/7BP is a Pax7-and Pax3-binding protein that regulates the proliferation of muscle precursor cells by an epigenetic mechanism. Cell Stem Cell11, 231-241.
55. Dietrich, S. (1999). Regulation of hypaxial muscle development. Cell Tissue Res. 296, 175-182.
56. Doddrell, R. D., Dun, X. P., Moate, R. M., Jessen, K. R., Mirsky, R. and Parkinson, D. B. (2012). Regulation of Schwann cell differentiation and proliferation by the Pax-3 transcription factor. Glia 60, 1269-1278.
57. Douglass, E. C., Valentine, M., Etcubanas, E., Parham, D., Webber, B. L., Houghton, P. J., Houghton, J. A. and Green, A. A. (1987). A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet. Cell Genet. 45, 148-155.
58. Dressler, G. R. (2011). Patterning and early cell lineage decisions in the developing kidney: the role of Pax genes. Pediatr. Nephrol. 26, 1387-1394.
59. Dziarmaga, A., Clark, P., Stayner, C., Julien, J. P., Torban, E., Goodyer, P. and Eccles, M. (2003). Ureteric bud apoptosis and renal hypoplasia in transgenic PAX2-Bax fetal mice mimics the renal-coloboma syndrome. J. Am. Soc. Nephrol. 14, 2767-2774.
60. Eberhard, D., Jiménez, G., Heavey, B. and Busslinger, M. (2000). Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family. EMBO J. 19, 2292-2303.
61. Eccles, M. R. and Schimmenti, L. A. (1999). Renal-coloboma syndrome: a multisystem developmental disorder caused by PAX2 mutations. Clin. Genet. 56, 1-9.
62. Eccles, M. R., Wallis, L. J., Fidler, A. E., Spurr, N. K., Goodfellow, P. J. and Reeve, A. E. (1992). Expression of the PAX2 gene in human fetal kidney and Wilms' tumor. Cell Growth Differ. 3, 279-289.
63. Elsas, F. J., Maumenee, I. H., Kenyon, K. R. and Yoder, F. (1977). Familial aniridia with preserved ocular function. Am. J. Ophthalmol. 83, 718-724.
64. Engleka, K. A., Gitler, A. D., Zhang, M., Zhou, D. D., High, F. A. and Epstein, J. A. (2005). Insertion of Cre into the Pax3 locus creates a new allele of Splotch and identifies unexpected Pax3 derivatives. Dev. Biol. 280, 396-406.
65. Epstein, J. A. (1996). Pax3, neural crest and cardiovascular development. Trends Cardiovasc. Med. 6, 255-260.
66. Epstein, D. J., Vekemans, M. and Gros, P. (1991). Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell 67, 767-774.
67. Ericson, J., Rashbass, P., Schedl, A., Brenner-Morton, S., Kawakami, A., van Heyningen, V., Jessell, T. M. and Briscoe, J. (1997). Pax6 controls progenitor cell identity and neuronal fate in response to graded Shh signaling. Cell 90, 169-180.
68. Ernfors, P. (2010). Cellular origin and developmental mechanisms during the formation of skin melanocytes. Exp. Cell Res. 316, 1397-1407.
69. Fang, M., Ren, H., Liu, J., Cadigan, K. M., Patel, S. R. and Dressler, G. R. (2009). Drosophila ptip is essential for anterior/posterior patterning in development and interacts with the PcG and trxG pathways. Development 136, 1929-1938.
70. Farhy, C., Elgart, M., Shapira, Z., Oron-Karni, V., Yaron, O., Menuchin, Y., Rechavi, G. and Ashery-Padan, R. (2013). Pax6 is required for normal cell-cycle exit and the differentiation kinetics of retinal progenitor cells. PLoS ONE 8, e76489.
71. François, J., Lentini, F. and de Rouck, F. (1984). Gillespie's syndrome (incomplete aniridia, cerebellar ataxia and oligophrenia). Ophthalmic Paediatr. Genet. 4, 29-32.
72. Franz, T. (1990). Defective ensheathment of motoric nerves in the Splotch mutant mouse. Acta Anat. (Basel) 138, 246-253.
73. Frazier-Bowers, S. A., Scott, M. R., Cavender, A., Mensah, J. and D'Souza, R. N. (2002). Mutational analysis of families affected with molar oligodontia. Connect. Tissue Res. 43, 296-300.
74. Fredericks, W. J., Galili, N., Mukhopadhyay, S., Rovera, G., Bennicelli, J., Barr, F. G. and Rauscher, F. J., 3rd (1995). The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Mol. Cell. Biol. 15, 1522-1535.
75. Galli, L. M., Knight, S. R., Barnes, T. L., Doak, A. K., Kadzik, R. S. and Burrus, L. W. (2008). Identification and characterization of subpopulations of Pax3 and Pax7 expressing cells in developing chick somites and limb buds. Dev. Dyn. 237, 1862-1874.
76. Gillespie, F. D. (1965). Aniridia, Cerebellar Ataxia, and Oligophrenia in Siblings. Arch. Ophthalmol. 73, 338-341.
77. Glaser, T., Lane, J. and Housman, D. (1990). A mouse model of the aniridia-Wilms tumor deletion syndrome. Science 250, 823-827.
78. Glaser, T., Walton, D. S. and Maas, R. L. (1992). Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene. Nat. Genet. 2, 232-239.
79. Glaser, T., Ton, C. C., Mueller, R., Petzl-Erler, M. L., Oliver, C., Nevin, N. C., Housman, D. E. and Maas, R. L. (1994). Absence of PAX6 gene mutations in Gillespie syndrome (partial aniridia, cerebellar ataxia, and mental retardation). Genomics 19, 145-148.
80. Gosmain, Y., Cheyssac, C., Heddad Masson, M., Dibner, C. and Philippe, J. (2011). Glucagon gene expression in the endocrine pancreas: the role of the transcription factor Pax6 in α-cell differentiation, glucagon biosynthesis and secretion. Diabetes Obes. Metab. 13 Suppl. 1, 31-38.
81. Götz, M., Stoykova, A. and Gruss, P. (1998). Pax6 controls radial glia differentiation in the cerebral cortex. Neuron 21, 1031-1044.
82. Goulding, M. D., Chalepakis, G., Deutsch, U., Erselius, J. R. and Gruss, P. (1991). Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J. 10, 1135-1147.
83. Goulding, M., Sterrer, S., Fleming, J., Balling, R., Nadeau, J., Moore, K. J., Brown, S. D., Steel, K. P. and Gruss, P. (1993). Analysis of the Pax-3 gene in the mouse mutant splotch. Genomics 17, 355-363.
84. Graziano, C., D'Elia, A. V., Mazzanti, L., Moscano, F., Guidelli Guidi, S., Scarano, E., Turchetti, D., Franzoni, E., Romeo, G., Damante, G. et al. (2007). A de novo nonsense mutation of PAX6 gene in a patient with aniridia, ataxia, and mental retardation. Am. J. Med. Genet. A. 143A, 1802-1805.
85. Günther, S., Kim, J., Kostin, S., Lepper, C., Fan, C. M. and Braun, T. (2013). Myf5-positive satellite cells contribute to Pax7-dependent long-term maintenance of adult muscle stem cells. Cell Stem Cell 13, 590-601.
86. Hackenbruch, Y., Meerhoff, E., Besio, R. and Cardoso, H. (1975). Familial bilateral optic nerve hypoplasia. Am. J. Ophthalmol. 79, 314-320.
87. Hans, S., Liu, D. and Westerfield, M. (2004). Pax8 and Pax2a function synergistically in otic specification, downstream of the Foxi1 and Dlx3b transcription factors. Development 131, 5091-5102.
88. Hanson, I. M., Fletcher, J. M., Jordan, T., Brown, A., Taylor, D., Adams, R. J., Punnett, H. H. and van Heyningen, V. (1994). Mutations at the PAX6 locus are found in heterogeneous anterior segment malformations including Peters' anomaly. Nat. Genet. 6, 168-173.
89. Hanson, I., Churchill, A., Love, J., Axton, R., Moore, T., Clarke, M., Meire, F. and van Heyningen, V. (1999). Missense mutations in the most ancient residues of the PAX6 paired domain underlie a spectrum of human congenital eye malformations. Hum. Mol. Genet. 8, 165-172.
90. Haubst, N., Berger, J., Radjendirane, V., Graw, J., Favor, J., Saunders, G. F., Stoykova, A. and Götz, M. (2004). Molecular dissection of Pax6 function: the specific roles of the paired domain and homeodomain in brain development. Development 131, 6131-6140.
91. Hayashi, Y., Inaba, T., Hanada, R. and Yamamoto, K. (1988). Translocation 2;8 in a congenital rhabdomyosarcoma. Cancer Genet. Cytogenet. 30, 343-345.
92. Henion, P. D. and Weston, J. A. (1997). Timing and pattern of cell fate restrictions in the neural crest lineage. Development 124, 4351-4359.
93. Higashide, T., Wada, T., Sakurai, M., Yokoyama, H. and Sugiyama, K. (2005). Macular abnormalities and optic disk anomaly associated with a new PAX2 missense mutation. Am. J. Ophthalmol. 139, 203-205.
94. Hill, R. E., Favor, J., Hogan, B. L., Ton, C. C., Saunders, G. F., Hanson, I. M., Prosser, J., Jordan, T., Hastie, N. D. and van Heyningen, V. (1991). Mouse small eye results from mutations in a paired-like homeobox-containing gene. Nature 354, 522-525.
95. Hoerter, J. D., Bradley, P., Casillas, A., Chambers, D., Denholm, C., Johnson, K. and Weiswasser, B. (2012). Extrafollicular dermal melanocyte stem cells and melanoma. Stem Cells Int. 2012, 407079.
96. Hornby, S. J., Adolph, S., Gilbert, C. E., Dandona, L. and Foster, A. (2000). Visual acuity in children with coloboma: clinical features and a new phenotypic classification system. Ophthalmology 107, 511-520.
97. Hornyak, T. J., Hayes, D. J., Chiu, L. Y. and Ziff, E. B. (2001). Transcription factors in melanocyte development: distinct roles for Pax-3 and Mitf. Mech. Dev. 101, 47-59.
98. Hoth, C. F., Milunsky, A., Lipsky, N., Sheffer, R., Clarren, S. K. and Baldwin, C. T. (1993). Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I). Am. J. Hum. Genet. 52, 455-462.
99. Hu He, K. H., Lorenzo, P. I., Brun, T., Jimenez Moreno, C. M., Aeberhard, D., Vallejo Ortega, J., Cornu, M., Thorel, F., Gjinovci, A., Thorens, B. et al. (2011). In vivo conditional Pax4 overexpression in mature islet β-cells prevents stress-induced hyperglycemia in mice. Diabetes 60, 1705-1715.
100. Huang, B., Pi, L., Chen, C., Yuan, F., Zhou, Q., Teng, J. and Jiang, T. (2012). WT1 and Pax2 re-expression is required for epithelial-mesenchymal transition in 5/6 nephrectomized rats and cultured kidney tubular epithelial cells. Cells Tissues Organs 195, 296-312.
101. Ishikiriyama, S. (1993). Gene for Waardenburg syndrome type I is located at 2q35, not at 2q37.3. Am. J. Med. Genet. 46, 608.
102. Jessen, K. R. and Mirsky, R. (2005). The origin and development of glial cells in peripheral nerves. Nat. Rev. Neurosci. 6, 671-682.
103. Jiang, Y. S., Jiang, T., Huang, B., Chen, P. S. and Ouyang, J. (2013). Epithelialmesenchymal transition of renal tubules: divergent processes of repairing in acute or chronic injury? Med. Hypotheses 81, 73-75.
104. Jonas, J. B. and Freisler, K. A. (1997). Bilateral congenital optic nerve head pits in monozygotic siblings. Am. J. Ophthalmol. 124, 844-846.
105. Jostes, B., Walther, C. and Gruss, P. (1990). The murine paired box gene, Pax7, is expressed specifically during the development of the nervous and muscular system. Mech. Dev. 33, 27-37.
106. Kapadia, H., Frazier-Bowers, S., Ogawa, T. and D'Souza, R. N. (2006). Molecular characterization of a novel PAX9 missense mutation causing posterior tooth agenesis. Eur. J. Hum. Genet. 14, 403-409.
107. Kawabe, Y., Wang, Y. X., McKinnell, I. W., Bedford, M. T. and Rudnicki, M. A. (2012). Carm1 regulates Pax7 transcriptional activity through MLL1/2 recruitment during asymmetric satellite stem cell divisions. Cell Stem Cell 11, 333-345.
108. Keller, C. and Guttridge, D. C. (2013). Mechanisms of impaired differentiation in rhabdomyosarcoma. FEBS J. 280, 4323-4334.
109. Keller, C., Arenkiel, B. R., Coffin, C. M., El-Bardeesy, N., DePinho, R. A. and Capecchi, M. R. (2004). Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev. 18, 2614-2626.
110. Kioussi, C., Gross, M. K. and Gruss, P. (1995). Pax3: a paired domain gene as a regulator in PNS myelination. Neuron 15, 553-562.
111. Kist, R., Watson, M., Wang, X., Cairns, P., Miles, C., Reid, D. J. and Peters, H. (2005). Reduction of Pax9 gene dosage in an allelic series of mouse mutants causes hypodontia and oligodontia. Hum. Mol. Genet. 14, 3605-3617.
112. Kivlin, J. D., Fineman, R. M., Crandall, A. S. and Olson, R. J. (1986). Peters' anomaly as a consequence of genetic and nongenetic syndromes. Arch. Ophthalmol. 104, 61-64.
113. Kooptiwut, S., Plengvidhya, N., Chukijrungroat, T., Sujjitjoon, J., Semprasert, N., Furuta, H. and Yenchitsomanus, P. T. (2012). Defective PAX4 R192H transcriptional repressor activities associated with maturity onset diabetes of the young and early onset-age of type 2 diabetes. J. Diabetes Complications 26, 343-347.
114. Kredo-Russo, S., Mandelbaum, A. D., Ness, A., Alon, I., Lennox, K. A., Behlke, M. A. and Hornstein, E. (2012). Pancreas-enriched miRNA refines endocrine cell differentiation. Development 139, 3021-3031.
115. Krispin, S., Nitzan, E. and Kalcheim, C. (2010). The dorsal neural tube: a dynamic setting for cell fate decisions. Dev. Neurobiol. 70, 796-812.
116. Kwang, S. J., Brugger, S. M., Lazik, A., Merrill, A. E., Wu, L. Y., Liu, Y. H., Ishii, M., Sangiorgi, F. O., Rauchman, M., Sucov, H. M. et al. (2002). Msx2 is an immediate downstream effector of Pax3 in the development of the murine cardiac neural crest. Development 129, 527-538.
117. Lagha, M., Kormish, J. D., Rocancourt, D., Manceau, M., Epstein, J. A., Zaret, K. S., Relaix, F. and Buckingham, M. E. (2008). Pax3 regulation of FGF signaling affects the progression of embryonic progenitor cells into the myogenic program. Genes Dev. 22, 1828-1837.
118. Lammi, L., Halonen, K., Pirinen, S., Thesleff, I., Arte, S. and Nieminen, P. (2003). A missense mutation in PAX9 in a family with distinct phenotype of oligodontia. Eur. J. Hum. Genet. 11, 866-871.
119. Lang, D., Chen, F., Milewski, R., Li, J., Lu, M. M. and Epstein, J. A. (2000). Pax3 is required for enteric ganglia formation and functions with Sox10 to modulate expression of c-ret. J. Clin. Invest. 106, 963-971.
120. Lang, D., Lu, M. M., Huang, L., Engleka, K. A., Zhang, M., Chu, E. Y., Lipner, S., Skoultchi, A., Millar, S. E. and Epstein, J. A. (2005). Pax3 functions at a nodal point in melanocyte stem cell differentiation. Nature 433, 884-887.
121. Le, N., Nagarajan, R., Wang, J. Y., Araki, T., Schmidt, R. E. and Milbrandt, J. (2005). Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc. Natl. Acad. Sci. USA 102, 2596-2601.
122. Le Douarin, N. M., Calloni, G. W. and Dupin, E. (2008). The stem cells of the neural crest. Cell Cycle 7, 1013-1019.
123. Lechtenberg, R. and Ferretti, C. (1981). Ataxia with aniridia of Gillespie: a case report. Neurology 31, 95-97.
124. Lek, M., Dias, J. M., Marklund, U., Uhde, C. W., Kurdija, S., Lei, Q., Sussel, L., Rubenstein, J. L., Matise, M. P., Arnold, H. H. et al. (2010). A homeodomain feedback circuit underlies step-function interpretation of a Shh morphogen gradient during ventral neural patterning. Development 137, 4051-4060.
125. Li, C. G. and Eccles, M. R. (2012). PAX Genes in Cancer; Friends or Foes? Front. Genet. 3, 6.
126. Li, J., Liu, K. C., Jin, F., Lu, M. M. and Epstein, J. A. (1999). Transgenic rescue of congenital heart disease and spina bifida in Splotch mice. Development 126, 2495-2503.
127. Liu, Y. (2004). Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J. Am. Soc. Nephrol. 15, 1-12.
128. Luan, Z., Liu, Y., Stuhlmiller, T. J., Marquez, J. and García-Castro, M. I. (2013). SUMOylation of Pax7 is essential for neural crest and muscle development. Cell. Mol. Life Sci. 70, 1793-1806.
129. Macchia, P. E., Lapi, P., Krude, H., Pirro, M. T., Missero, C., Chiovato, L., Souabni, A., Baserga, M., Tassi, V., Pinchera, A. et al. (1998). PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat. Genet. 19, 83-86.
130. Mackereth, M. D., Kwak, S. J., Fritz, A. and Riley, B. B. (2005). Zebrafish pax8 is required for otic placode induction and plays a redundant role with Pax2 genes in the maintenance of the otic placode. Development 132, 371-382.
131. Marquardt, T., Ashery-Padan, R., Andrejewski, N., Scardigli, R., Guillemot, F. and Gruss, P. (2001). Pax6 is required for the multipotent state of retinal progenitor cells. Cell 105, 43-55.
132. Mastick, G. S., Davis, N. M., Andrew, G. L. and Easter, S. S., Jr (1997). Pax-6 functions in boundary formation and axon guidance in the embryonic mouse forebrain. Development 124, 1985-1997.
133. Matsunaga, E., Araki, I. and Nakamura, H. (2000). Pax6 defines the dimesencephalic boundary by repressing En1 and Pax2. Development 127, 2357-2365.
134. Matsuo, T., Osumi-Yamashita, N., Noji, S., Ohuchi, H., Koyama, E., Myokai, F., Matsuo, N., Taniguchi, S., Doi, H., Iseki, S. et al. (1993). A mutation in the Pax-6 gene in rat small eye is associated with impaired migration of midbrain crest cells. Nat. Genet. 3, 299-304.
135. Mauvais-Jarvis, F., Smith, S. B., Le May, C., Leal, S. M., Gautier, J. F., Molokhia, M., Riveline, J. P., Rajan, A. S., Kevorkian, J. P., Zhang, S. et al. (2004). PAX4 gene variations predispose to ketosis-prone diabetes. Hum. Mol. Genet. 13, 3151-3159.
136. Mayanil, C. S., George, D., Freilich, L., Miljan, E. J., Mania-Farnell, B., McLone, D. G. and Bremer, E. G. (2001). Microarray analysis detects novel Pax3 downstream target genes. J. Biol. Chem. 276, 49299-49309.
137. Mayanil, C. S., Pool, A., Nakazaki, H., Reddy, A. C., Mania-Farnell, B., Yun, B., George, D., McLone, D. G. and Bremer, E. G. (2006). Regulation of murine TGFbeta2 by Pax3 during early embryonic development. J. Biol. Chem. 281, 24544-24552.
138. McCarroll, M. N., Lewis, Z. R., Culbertson, M. D., Martin, B. L., Kimelman, D. and Nechiporuk, A. V. (2012). Graded levels of Pax2a and Pax8 regulate cell differentiation during sensory placode formation. Development 139, 2740-2750.
139. McKinnell, I. W., Ishibashi, J., Le Grand, F., Punch, V. G., Addicks, G. C., Greenblatt, J. F., Dilworth, F. J. and Rudnicki, M. A. (2008). Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex. Nat. Cell Biol. 10, 77-84.
140. Medic, S. and Ziman, M. (2010). PAX3 expression in normal skin melanocytes and melanocytic lesions (naevi and melanomas). PLoS ONE 5, e9977.
141. Meeus, L., Gilbert, B., Rydlewski, C., Parma, J., Roussie, A. L., Abramowicz, M., Vilain, C., Christophe, D., Costagliola, S. and Vassart, G. (2004). Characterization of a novel loss of function mutation of PAX8 in a familial case of congenital hypothyroidism with in-place, normal-sized thyroid. J. Clin. Endocrinol. Metab. 89, 4285-4291.
142. Mi, D., Carr, C. B., Georgala, P. A., Huang, Y. T., Manuel, M. N., Jeanes, E., Niisato, E., Sansom, S. N., Livesey, F. J., Theil, T. et al. (2013). Pax6 exerts regional control of cortical progenitor proliferation via direct repression of Cdk6 and hypophosphorylation of pRb. Neuron 78, 269-284.
143. Milet, C., Maczkowiak, F., Roche, D. D. and Monsoro-Burq, A. H. (2013). Pax3 and Zic1 drive induction and differentiation of multipotent, migratory, and functional neural crest in Xenopus embryos. Proc. Natl. Acad. Sci. USA 110, 5528-5533.
144. Moase, C. E. and Trasler, D. G. (1990). Delayed neural crest cell emigration from Sp and Spd mouse neural tube explants. Teratology 42, 171-182.
145. Monsoro-Burq, A. H., Wang, E. and Harland, R. (2005). Msx1 and Pax3 cooperate to mediate FGF8 and WNT signals during Xenopus neural crest induction. Dev. Cell 8, 167-178.
146. Mostowska, A., Biedziak, B. and Trzeciak, W. H. (2006). A novel mutation in PAX9 causes familial form of molar oligodontia. Eur. J. Hum. Genet. 14, 173-179.
147. Mullighan, C. G., Goorha, S., Radtke, I., Miller, C. B., Coustan-Smith, E., Dalton, J. D., Girtman, K., Mathew, S., Ma, J., Pounds, S. B. et al. (2007). Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446, 758-764.
148. Murdoch, B., DelConte, C. and García-Castro, M. I. (2012). Pax7 lineage contributions to the mammalian neural crest. PLoS ONE 7, e41089.
149. Nakazaki, H., Reddy, A. C., Mania-Farnell, B. L., Shen, Y. W., Ichi, S., McCabe, C., George, D., McLone, D. G., Tomita, T. and Mayanil, C. S. (2008). Key basic helixloop-helix transcription factor genes Hes1 and Ngn2 are regulated by Pax3 during mouse embryonic development. Dev. Biol. 316, 510-523.
150. Nakazaki, H., Shen, Y. W., Yun, B., Reddy, A., Khanna, V., Mania-Farnell, B., Ichi, S., McLone, D. G., Tomita, T. and Mayanil, C. S. (2009). Transcriptional regulation by Pax3 and TGFbeta2 signaling: a potential gene regulatory network in neural crest development. Int. J. Dev. Biol. 53, 69-79.
151. Nelson, J., Flaherty, M. and Grattan-Smith, P. (1997). Gillespie syndrome: a report of two further cases. Am. J. Med. Genet. 71, 134-138.
152. Nguyen, L. V., Vanner, R., Dirks, P. and Eaves, C. J. (2012). Cancer stem cells: an evolving concept. Nat. Rev. Cancer 12, 133-143.
153. Ninkovic, J., Steiner-Mezzadri, A., Jawerka, M., Akinci, U., Masserdotti, G., Petricca, S., Fischer, J., von Holst, A., Beckers, J., Lie, C. D. et al. (2013). The BAF complex interacts with Pax6 in adult neural progenitors to establish a neurogenic cross-regulatory transcriptional network. Cell Stem Cell 13, 403-418.
154. Nishimoto, K., Iijima, K., Shirakawa, T., Kitagawa, K., Satomura, K., Nakamura, H. and Yoshikawa, N. (2001). PAX2 gene mutation in a family with isolated renal hypoplasia. J. Am. Soc. Nephrol. 12, 1769-1772.
155. Nutt, S. L. and Busslinger, M. (1999). Monoallelic expression of Pax5: a paradigm for the haploinsufficiency of mammalian Pax genes? Biol. Chem. 380, 601-611.
156. Nutt, S. L., Vambrie, S., Steinlein, P., Kozmik, Z., Rolink, A., Weith, A. and Busslinger, M. (1999). Independent regulation of the two Pax5 alleles during B-cell development. Nat. Genet. 21, 390-395.
157. O'Donnell, F. E., Jr and Pappas, H. R. (1982). Autosomal dominant foveal hypoplasia and presenile cataracts. A new syndrome. Arch. Ophthalmol. 100, 279-281.
158. Olaopa, M., Zhou, H. M., Snider, P., Wang, J., Schwartz, R. J., Moon, A. M. and Conway, S. J. (2011). Pax3 is essential for normal cardiac neural crest morphogenesis but is not required during migration nor outflow tract septation. Dev. Biol. 356, 308-322.
159. Oliver, M. D., Dotan, S. A., Chemke, J. and Abraham, F. A. (1987). Isolated foveal hypoplasia. Br. J. Ophthalmol. 71, 926-930.
160. Opdecamp, K., Nakayama, A., Nguyen, M. T., Hodgkinson, C. A., Pavan, W. J. and Arnheiter, H. (1997). Melanocyte development in vivo and in neural crest cell cultures: crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor. Development 124, 2377-2386.
161. Pasut, A. and Rudnicki, M. A. (2012). The long, the short, and the micro: a polyA tale of Pax3 in satellite cells. Cell Stem Cell 10, 237-238.
162. Patel, S. R., Kim, D., Levitan, I. and Dressler, G. R. (2007). The BRCT-domain containing protein PTIP links PAX2 to a histone H3, lysine 4 methyltransferase complex. Dev. Cell 13, 580-592.
163. Patel, S. R., Ranghini, E. and Dressler, G. R. (2013). Mechanisms of gene activation and repression by Pax proteins in the developing kidney. Pediatr. Nephrol.
164. Pearce, W. G., Mielke, B. W., Hassard, D. T., Climenhaga, H. W., Climenhaga, D. B. and Hodges, E. J. (1995). Autosomal dominant keratitis: a possible aniridia variant. Can. J. Ophthalmol. 30, 131-137.
165. Perrotti, D., Jamieson, C., Goldman, J. and Skorski, T. (2010). Chronic myeloid leukemia: mechanisms of blastic transformation. J. Clin. Invest. 120, 2254-2264.
166. Peters, H., Wilm, B., Sakai, N., Imai, K., Maas, R. and Balling, R. (1999). Pax1 and Pax9 synergistically regulate vertebral column development. Development 126, 5399-5408.
167. Pfeffer, P. L., Bouchard, M. and Busslinger, M. (2000). Pax2 and homeodomain proteins cooperatively regulate a 435 bp enhancer of the mouse Pax5 gene at the midbrain-hindbrain boundary. Development 127, 1017-1028.
168. Pfeffer, P. L., Payer, B., Reim, G., di Magliano, M. P. and Busslinger, M. (2002). The activation and maintenance of Pax2 expression at the mid-hindbrain boundary is controlled by separate enhancers. Development 129, 307-318.
169. Pfeifer, A., Courtney, M., Ben-Othman, N., Al-Hasani, K., Gjernes, E., Vieira, A., Druelle, N., Avolio, F., Faurite, B., Mansouri, A. et al. (2013). Induction of multiple cycles of pancreatic β-cell replacement. Cell Cycle 12, 3243-3244.
170. Poleev, A., Wendler, F., Fickenscher, H., Zannini, M. S., Yaginuma, K., Abbott, C. and Plachov, D. (1995). Distinct functional properties of three human paired-boxprotein, PAX8, isoforms generated by alternative splicing in thyroid, kidney and Wilms' tumors. Eur. J. Biochem. 228, 899-911.
171. Pongpudpunth, M., Bhawan, J., Al-Natour, S. H. and Mahalingam, M. (2010). Nestin-positive stem cells in neurofibromas from patients with neurofibromatosis type 1-tumorigenic or incidental? Am. J. Dermatopathol. 32, 574-577.
172. Ramaesh, T., Collinson, J. M., Ramaesh, K., Kaufman, M. H., West, J. D. and Dhillon, B. (2003). Corneal abnormalities in Pax6+/-small eye mice mimic human aniridia-related keratopathy. Invest. Ophthalmol. Vis. Sci. 44, 1871-1878.
173. Ramaesh, T., Ramaesh, K., Leask, R., Springbett, A., Riley, S. C., Dhillon, B. and West, J. D. (2006). Increased apoptosis and abnormal wound-healing responses in the heterozygous Pax6+/-mouse cornea. Invest. Ophthalmol. Vis. Sci. 47, 1911-1917.
174. Relaix, F., Rocancourt, D., Mansouri, A. and Buckingham, M. (2005). A Pax3/Pax7-dependent population of skeletal muscle progenitor cells. Nature 435, 948-953.
175. Rocheteau, P., Gayraud-Morel, B., Siegl-Cachedenier, I., Blasco, M. A. and Tajbakhsh, S. (2012). A subpopulation of adult skeletal muscle stem cells retains all template DNA strands after cell division. Cell 148, 112-125.
176. Roeb, W., Boyer, A., Cavenee, W. K. and Arden, K. C. (2007). PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1. Proc. Natl. Acad. Sci. USA 104, 18085-18090.
177. Rolink, A., Nutt, S., Busslinger, M., ten Boekel, E., Seidl, T., Andersson, J. and Melchers, F. (1999). Differentiation, dedifferentiation, and redifferentiation of Blineage lymphocytes: roles of the surrogate light chain and the Pax5 gene. Cold Spring Harb. Symp. Quant. Biol. 64, 21-26.
178. Rudnicki, M. A., Le Grand, F., McKinnell, I. and Kuang, S. (2008). The molecular regulation of muscle stem cell function. Cold Spring Harb. Symp. Quant. Biol. 73, 323-331.
179. Sansom, S. N., Griffiths, D. S., Faedo, A., Kleinjan, D. J., Ruan, Y., Smith, J., van Heyningen, V., Rubenstein, J. L. and Livesey, F. J. (2009). The level of the transcription factor Pax6 is essential for controlling the balance between neural stem cell self-renewal and neurogenesis. PLoS Genet. 5, e1000511.
180. Sarsfield, J. K. (1971). The syndrome of congenital cerebellar ataxia, aniridia and mental retardation. Dev. Med. Child Neurol. 13, 508-511.
181. Sato, T., Sasai, N. and Sasai, Y. (2005). Neural crest determination by co-activation of Pax3 and Zic1 genes in Xenopus ectoderm. Development 132, 2355-2363.
182. Schimmenti, L. A., Cunliffe, H. E., McNoe, L. A., Ward, T. A., French, M. C., Shim, H. H., Zhang, Y. H., Proesmans, W., Leys, A., Byerly, K. A. et al. (1997). Further delineation of renal-coloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations. Am. J. Hum. Genet. 60, 869-878.
183. Schnittger, S., Rao, V. V., Deutsch, U., Gruss, P., Balling, R. and Hansmann, I. (1992). Pax1, a member of the paired box-containing class of developmental control genes, is mapped to human chromosome 20p11.2 by in situ hybridization (ISH and FISH). Genomics 14, 740-744.
184. Schubert, F. R., Tremblay, P., Mansouri, A., Faisst, A. M., Kammandel, B., Lumsden, A., Gruss, P. and Dietrich, S. (2001). Early mesodermal phenotypes in splotch suggest a role for Pax3 in the formation of epithelial somites. Dev. Dyn. 222, 506-521.
185. Schwarz, M., Alvarez-Bolado, G., Dressler, G., Urbánek, P., Busslinger, M. and Gruss, P. (1999). Pax2/5 and Pax6 subdivide the early neural tube into three domains. Mech. Dev. 82, 29-39.
186. Seale, P., Sabourin, L. A., Girgis-Gabardo, A., Mansouri, A., Gruss, P. and Rudnicki, M. A. (2000). Pax7 is required for the specification of myogenic satellite cells. Cell 102, 777-786.
187. Serbedzija, G. N., Bronner-Fraser, M. and Fraser, S. E. (1994). Developmental potential of trunk neural crest cells in the mouse. Development 120, 1709-1718.
188. Shaham, O., Gueta, K., Mor, E., Oren-Giladi, P., Grinberg, D., Xie, Q., Cvekl, A., Shomron, N., Davis, N., Keydar-Prizant, M. et al. (2013). Pax6 regulates gene expression in the vertebrate lens through miR-204. PLoS Genet. 9, e1003357.
189. Shalom-Feuerstein, R., Serror, L., De La Forest Divonne, S., Petit, I., Aberdam, E., Camargo, L., Damour, O., Vigouroux, C., Solomon, A., Gaggioli, C. et al. (2012). Pluripotent stem cell model reveals essential roles for miR-450b-5p and miR-184 in embryonic corneal lineage specification. Stem Cells 30, 898-909.
190. Shaw, M. W., Falls, H. F. and Neel, J. V. (1960). Congenital Aniridia. Am. J. Hum. Genet. 12, 389-415.
191. Shimajiri, Y., Sanke, T., Furuta, H., Hanabusa, T., Nakagawa, T., Fujitani, Y., Kajimoto, Y., Takasu, N. and Nanjo, K. (2001). A missense mutation of Pax4 gene (R121W) is associated with type 2 diabetes in Japanese. Diabetes 50, 2864-2869.
192. Sisodiya, S. M., Free, S. L., Williamson, K. A., Mitchell, T. N., Willis, C., Stevens, J. M., Kendall, B. E., Shorvon, S. D., Hanson, I. M., Moore, A. T. et al. (2001). PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans. Nat. Genet. 28, 214-216.
193. Smith, C. A. and Tuan, R. S. (1994). Human PAX gene expression and development of the vertebral column. Clin. Orthop. Relat. Res. 302, 241-250.
194. Sobngwi, E. and Gautier, J. F. (2002). Adult-onset idiopathic Type I or ketosis-prone Type II diabetes: evidence to revisit diabetes classification. Diabetologia 45, 283-285.
195. Soleimani, V. D., Punch, V. G., Kawabe, Y., Jones, A. E., Palidwor, G. A., Porter, C. J., Cross, J. W., Carvajal, J. J., Kockx, C. E., van Jeken, W. F. et al. (2012). Transcriptional dominance of Pax7 in adult myogenesis is due to high-affinity recognition of homeodomain motifs. Dev. Cell 22, 1208-1220.
196. St-Onge, L., Sosa-Pineda, B., Chowdhury, K., Mansouri, A. and Gruss, P. (1997). Pax6 is required for differentiation of glucagon-producing alpha-cells in mouse pancreas. Nature 387, 406-409.
197. Stockton, D. W., Das, P., Goldenberg, M., D'Souza, R. N. and Patel, P. I. (2000). Mutation of PAX9 is associated with oligodontia. Nat. Genet. 24, 18-19.
198. Suter, D. M., Tirefort, D., Julien, S. and Krause, K. H. (2009). A Sox1 to Pax6 switch drives neuroectoderm to radial glia progression during differentiation of mouse embryonic stem cells. Stem Cells 27, 49-58.
199. Tassabehji, M., Read, A. P., Newton, V. E., Harris, R., Balling, R., Gruss, P. and Strachan, T. (1992). Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature 355, 635-636.
200. Tavassoli, K., Rüger, W. and Horst, J. (1997). Alternative splicing in PAX2 generates a new reading frame and an extended conserved coding region at the carboxy terminus. Hum. Genet. 101, 371-375.
201. Tekin, M., Bodurtha, J. N., Nance, W. E. and Pandya, A. (2001). Waardenburg syndrome type 3 (Klein-Waardenburg syndrome) segregating with a heterozygous deletion in the paired box domain of PAX3: a simple variant or a true syndrome? Clin. Genet. 60, 301-304.
202. Tellier, A. L., Cormier-Daire, V., Abadie, V., Amiel, J., Sigaudy, S., Bonnet, D., de Lonlay-Debeney, P., Morrisseau-Durand, M. P., Hubert, P., Michel, J. L. et al. (1998). CHARGE syndrome: report of 47 cases and review. Am. J. Med. Genet. 76, 402-409.
203. Theriault, F. M., Nuthall, H. N., Dong, Z., Lo, R., Barnabe-Heider, F., Miller, F. D. and Stifani, S. (2005). Role for Runx1 in the proliferation and neuronal differentiation of selected progenitor cells in the mammalian nervous system. J. Neurosci. 25, 2050-2061.
204. Ticho, B. H., Hilchie-Schmidt, C., Egel, R. T., Traboulsi, E. I., Howarth, R. J. and Robinson, D. (2006). Ocular findings in Gillespie-like syndrome: association with a new PAX6 mutation. Ophthalmic Genet. 27, 145-149.
205. Ton, C. C., Hirvonen, H., Miwa, H., Weil, M. M., Monaghan, P., Jordan, T., van Heyningen, V., Hastie, N. D., Meijers-Heijboer, H., Drechsler, M. et al. (1991). Positional cloning and characterization of a paired box-and homeobox-containing gene from the aniridia region. Cell 67, 1059-1074.
206. Tremblay, P., Dietrich, S., Mericskay, M., Schubert, F. R., Li, Z. and Paulin, D. (1998). A crucial role for Pax3 in the development of the hypaxial musculature and the long-range migration of muscle precursors. Dev. Biol. 203, 49-61.
207. Tuoc, T. C., Narayanan, R. and Stoykova, A. (2013). BAF chromatin remodeling complex: cortical size regulation and beyond. Cell Cycle 12, 2953-2959.
208. Underhill, D. A. (2012). PAX proteins and fables of their reconstruction. Crit. Rev. Eukaryot. Gene Expr. 22, 161-177.
209. Verhulst, S., Smet, H., Ceulemans, B., Geerts, Y. and Tassignon, M. J. (1993). Gillespie syndrome, partial aniridia, cerebellar ataxia and mental retardation in mother and daughter. Bull. Soc. Belge Ophtalmol. 250, 37-42.
210. Vilain, C., Rydlewski, C., Duprez, L., Heinrichs, C., Abramowicz, M., Malvaux, P., Renneboog, B., Parma, J., Costagliola, S. and Vassart, G. (2001). Autosomal dominant transmission of congenital thyroid hypoplasia due to loss-of-function mutation of PAX8. J. Clin. Endocrinol. Metab. 86, 234-238.
211. von Maltzahn, J., Jones, A. E., Parks, R. J. and Rudnicki, M. A. (2013). Pax7 is critical for the normal function of satellite cells in adult skeletal muscle. Proc. Natl. Acad. Sci. USA 110, 16474-16479.
212. Vorobyov, E., Mertsalov, I., Dockhorn-Dworniczak, B., Dworniczak, B. and Horst, J. (1997). The genomic organization and the full coding region of the human PAX7 gene. Genomics 45, 168-174.
213. Walcher, T., Xie, Q., Sun, J., Irmler, M., Beckers, J., Öztürk, T., Niessing, D., Stoykova, A., Cvekl, A., Ninkovic, J. et al. (2013). Functional dissection of the paired domain of Pax6 reveals molecular mechanisms of coordinating neurogenesis and proliferation. Development 140, 1123-1136.
214. Wallin, J., Eibel, H., Neubüser, A., Wilting, J., Koseki, H. and Balling, R. (1996). Pax1 is expressed during development of the thymus epithelium and is required for normal T-cell maturation. Development 122, 23-30.
215. Walther, C. and Gruss, P. (1991). Pax-6, a murine paired box gene, is expressed in the developing CNS. Development 113, 1435-1449.
216. Wang, Q., Kumar, S., Slevin, M. and Kumar, P. (2006). Functional analysis of alternative isoforms of the transcription factor PAX3 in melanocytes in vitro. Cancer Res. 66, 8574-8580.
217. Wang, Q., Kumar, S., Mitsios, N., Slevin, M. and Kumar, P. (2007). Investigation of downstream target genes of PAX3c, PAX3e and PAX3g isoforms in melanocytes by microarray analysis. Int. J. Cancer 120, 1223-1231.
218. Wang-Wuu, S., Soukup, S., Ballard, E., Gotwals, B. and Lampkin, B. (1988). Chromosomal analysis of sixteen human rhabdomyosarcomas. Cancer Res. 48, 983-987.
219. Ward, T. A., Nebel, A., Reeve, A. E. and Eccles, M. R. (1994). Alternative messenger RNA forms and open reading frames within an additional conserved region of the human PAX-2 gene. Cell Growth Differ. 5, 1015-1021.
220. White, R. B. and Ziman, M. R. (2008). Genome-wide discovery of Pax7 target genes during development. Physiol. Genomics 33, 41-49.
221. Wittig, E. O., Moreira, C. A., Freire-Maia, N. and Vianna-Morgante, A. M. (1988). Partial aniridia, cerebellar ataxia, and mental deficiency (Gillespie syndrome) in two brothers. Am. J. Med. Genet. 30, 703-708.
222. Wollnik, B., Tukel, T., Uyguner, O., Ghanbari, A., Kayserili, H., Emiroglu, M. and Yuksel-Apak, M. (2003). Homozygous and heterozygous inheritance of PAX3 mutations causes different types of Waardenburg syndrome. Am. J. Med. Genet. A.122A, 42-45.
223. Yang, X. M. and Trasler, D. G. (1991). Abnormalities of neural tube formation in prespina bifida splotch-delayed mouse embryos. Teratology 43, 643-657.
224. Yang, Y., Chauhan, B. K., Cveklova, K. and Cvekl, A. (2004). Transcriptional regulation of mouse alphaB-and gammaF-crystallin genes in lens: opposite promoter-specific interactions between Pax6 and large Maf transcription factors. J. Mol. Biol. 344, 351-368.
225. Yu, W. M., Feltri, M. L., Wrabetz, L., Strickland, S. and Chen, Z. L. (2005). Schwann cell-specific ablation of laminin gamma1 causes apoptosis and prevents proliferation. J. Neurosci. 25, 4463-4472.
226. Zavadil, J., Bitzer, M., Liang, D., Yang, Y. C., Massimi, A., Kneitz, S., Piek, E. and Bottinger, E. P. (2001). Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc. Natl. Acad. Sci. USA 98, 6686-6691.
227. Zhang, X., Huang, C. T., Chen, J., Pankratz, M. T., Xi, J., Li, J., Yang, Y., Lavaute, T. M., Li, X. J., Ayala, M. et al. (2010). Pax6 is a human neuroectoderm cell fate determinant. Cell Stem Cell 7, 90-100.
228. Zlotogora, J. (1995). X-linked albinism-deafness syndrome and Waardenburg syndrome type II: a hypothesis. Am. J. Med. Genet. 59, 386-387.